Advocacy

Rare disease advocacy groups amplify the voices of patients, caregivers, and communities to drive awareness, funding, and policy changes. Whether it’s pushing for faster diagnoses, access to treatments, or equitable healthcare policies, advocates play a vital role in transforming lives.

More

First-Line Therapy Approved for Rare Lung Cancer | The CheckRare Brief Ep 7

  This week, three developments highlight the rapidly changing rare disease treatment landscape: a Phase 3 setback in Angelman syndrome, continued competition in hereditary angioedema, and an...

New Huntington’s Disease Gene Therapy Application | The CheckRare Brief Ep 6

  In this episode of The CheckRare Brief, we discuss two recent FDA approvals for rare diseases, including Zanvastro for Alexander disease and Besremi for essential thrombocythemia (ET). We...

Getting a Rare Disease Drug Approved Is Only Half the Battle | The CheckRare Brief Ep 4

  FDA approval is a major milestone, but for patients with rare diseases, it is only the beginning. In this episode of The CheckRare Brief, we look at two new rare disease approvals, ongoing...

FDA Approves New Narcolepsy Treatment | The CheckRare Brief

  On this week’s episode of The CheckRare Brief, we discuss FDA's approval of Orzeyful (oveporexton) to treat patients with narcolepsy type 1, CAMP4’s first-in-human clinical trial for patients...

Recent Videos

FDA Approves First Treatment for Menkes Disease

FDA Approves First Treatment for Menkes Disease

The U.S FDA has approved Zycubo (copper histidinate) for the treatment of pediatric patients with Menkes disease.